|
Press Release
ImaCor Announces 24/7 hTEE Clinical Support Program
Clinical Specialists Available Around-the-Clock to Provide Customer Service
GARDEN CITY NY, July 2, 2013 -- ImaCor's 24/7 hTEE Clinical Support Program ensures that a senior member of the company's clinical specialist team is always available via phone, text, and video-chat modalities to provide support to clinicians working at the patient bedside. 24/7 hTEE Clinical Support is an enhancement to the ImaCor Customer Service Program, and aligns with ImaCor's educational commitment to their customers. |
VA Federal Supply Schedule
12
ImaCor Inc. is pleased to announce that it is a participant in the Prime Vendor Program and has a Federal Supply Schedule (FSS) #V797P-4464B by the Department of Veterans Affairs.
Please contact us at info@imacorinc.com or 1.877.244.0657 if you would like to speak about hTEE at your VA Hospital.
|
|
Conferences
72nd AAST Annual Meeting & Clinical Congress of Acute Care Surgery
Sept 18-21, 2013
San Francisco, CA
|
|
Photos
 | |
William T. O'Byrne III MD and Kevin Ellis RN imaging in the CICU at the University of Alabama at Birmingham Hospital
|
|
|
 | |
Ion Miclea MD PhD and Florentina Matache MD from the IInstitutul de Urgenta pentru Boli Cardiovasculare conducting an hTEE exam on a high risk cardiac patient
|
|
 | |
Serban Bubenek MD, PhD (center) from the IInstitutul de Urgenta pentru Boli Cardiovasculare instructs attending (left) on Zura EVO.
|
|
Contact Us www.ImaCorInc.com info@ImaCorInc.com +1.516.393.0970 or 1.877.244.0657 |
|
|
|
Hemodynamic Assessment of Critically Ill Patients Using a Miniaturized Transesophageal Echocardiography Probe  Cioccari L, Baur H-R, Berger D, Wiegand J, Takala J, Merz TM. Hemodynamic assessment of critically ill patients using a miniaturized transesophageal echocardiography probe. Critical Care 2013, 17:R121 doi:10.1186/cc12793. Major Study by Leading Physicians at Bern University Hospital Answers Three Key Questions About hTEE
Harold M. Hastings PhD, Co-Founder/CTO
I am really excited by a recent study by Drs. Cioccari, Baur, Berger, Wiegand, Takala, and Merz e-published in the high-impact journal Critical Care June 20; this study by leading physician users at Bern University Hospital answers three important "frequently asked questions" about training, utility, and accuracy.
Question 1. "Can I learn to do hTEE?"
Answer: "Fourteen ICU staff specialists with no previous TEE experience received 6 hours of training as mTEE [hTEE - Ciocarri et al. use mTEE for miniaturized TEE] operators."
Question 2. "Does hTEE yield useful information?"
Answer: "Hemodynamic monitoring of ICU patients using the mTEE-system provides additional, valid data for the management of critically ill patients." Ciocarri et al. cite a limitation, "Further studies are required to assess the impact of hemodynamic monitoring by mTEE on relevant patient outcomes." A recent study by Vieillard-Baron et al. (A pilot study on safety and clinical utility of a single-use 72-hour indwelling transesophageal echocardiography probe, Intensive Care Medicine 2013*) addressed this limitation.
Question 3. An attending asks, "How accurately can my resident (or PA or NP) perform quantitative assessments With hTEE?"
Answer: Figure 3 from Ciocarri et al., reprinted above, addresses this issue - note the close agreement between FAC measured by newly trained ICU specialists and measurement by a trained cardiologist.
|
 VA-ECMO Weaning in Intensive Care Unit Using Miniaturized Transesophageal Echocardiography
Hitoshi Hirose MD PhD, Konrad Sarosiek MD, Harold Hastings PhD, Harrison T. Pitcher MD, Nicholas Cavarocchi MD Thomas Jefferson University Hospital, Philadelphia PA, USA
Hofstra University, Hempstead NY, USA (also Co-Founder/CTO)
TJU hTEE-Guided ECMO Weaning Protocol Presented at ASAIO, Chicago, June 13, 2013.
Harold M. Hastings PhD, Co-Founder/CTO
 | | Harrison Pitcher MD and Konrad Sarosiek MD at ASAIO 2013 |
The TJU study found that "the positive predictive value for ventricular recovery by hTEE was 100% using the standardized ECMO weaning protocol (95% confidence interval 73 - 100%)" and concluded that their "hTEE-guided ECMO weaning protocol accurately predicted the ability to successfully wean ECMO." Weaning ECMO presents a unique challenge as blood flows shift dramatically and the heart is called upon to provide full cardiac output previously supported by ECMO.
This study demonstrates the advantages of direct visualization of cardiac filling and bi-ventricular function in managing throughout the four to six hour weaning protocol.
   
Read More
Go to Top
|
Haemodynamic Monitoring with hTOE? A Case Series Report
S. Treskatsch MD, M. Habicher MD, J.P. Braun MD, C. Spies MD, M. Sander MD, Charité-Universitaetsmedizin Berlin Germany (Excerpted, please click to read the full report)
Results:
Results of the hTOE exams changed the current therapy in nearly all cases, e.g. a) further volume administration in patients with severely reduced left ventricular function, b) reoperation due to pericardial tamponade, c) supporting right ventricular function due to new postoperative failure, etc. In three cases hTOE changed clinical management despite measurements from an inherent PAC and/or PICCO.
|
I recognize the valuable academic contributions that are being made in the name of hTEE, and I am pleased to spotlight them in this newsletter. The Bern University Hospital study was published in the journal, Critical Care, Thomas Jefferson University Hospital's hTEE ECMO weaning protocol was presented at the American Society for Artificial Internal Organs (ASAIO), an Charité Universitaetsmedizin Berlin's June 7th presentation of findings from their first 10 patients scanned with hTEE was presented at EACTA's annual meeting in Barcelona. It is very rewarding to see the impact of hemodynamic management.
I would also like to draw your attention to the Comprehensive Advanced Heart Failure Summit, hosted by Vanderbilt Heart and Vascular Institute, which will be held in early August (August 9-10, 2013). This summit brings together VAD and Advanced Heart Failure leaders throughout the United States with Simon Maltais MD, PhD, from Vanderbilt Heart and Vascular Institute, heading the discussion. Chad Wagner MD, also from Vanderbilt, will be presenting hTEE in his session on Guided Management of Patients with Advanced Heart Failure Therapies. We are honored to have hTEE included in the conversation of such a distinguished group.
hTEE offers unique benefits for VAD recipients, including the adjustment of VAD settings directly from the bedside in the ICU. hTEE eliminates the guesswork in RPM settings in the VAD recipient. Moreover, hTEE addresses the ever-present daily trials of hemodynamic management in unstable patients. We encourage you to register for this valuable CME course soon.
Have a safe & healthy summer.
Kind regards,
Peter Pellerito
President & CEO
|
Recent Issues of ImaCor Newsletters
|
|
|
|
|
